共 285 条
[1]
Pardoll DM(2012)The blockade of immune checkpoints in cancer immunotherapy Nat Rev Cancer 12 252-264
[2]
Robert C(2015)Pembrolizumab versus ipilimumab in advanced melanoma N Engl J Med 372 2521-2532
[3]
Schachter J(2019)Updated analysis of KEYNOTE-024: pembrolizumab versus platinum-based chemotherapy for advanced non-small-cell lung cancer with PD-L1 tumor proportion score of 50% or greater Faculty Sci Med Health - Papers: Part B 37 537-1728
[4]
Long GV(2018)Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis JAMA Oncol 4 1721-1589
[5]
Reck M(2018)Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study Lancet Oncol 19 1579-1764
[6]
Rodríguez-Abreu D(2018)Myocarditis in patients treated with immune checkpoint inhibitors J Am Coll Cardiol 71 1755-1911
[7]
Robinson AG(2017)Immune checkpoint inhibitors in challenging populations Cancer 123 1904-723
[8]
Wang DY(2022)The role of immune checkpoints in cardiovascular disease Front Pharmacol 13 4065-1747
[9]
Salem JE(2021)PD-L1 (programmed death ligand 1) as a marker of acute cellular rejection after heart transplantation Circ Heart Fail 14 E008563-1755
[10]
Cohen JV(2021)Immune checkpoint inhibitor (ICI) combination therapy compared to monotherapy in advanced solid cancer: a systematic review J Cancer 12 1318-927